Last reviewed · How we verify

NCT05975216: Relink

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

Completed Last updated 12 August 2025
What this trial tests

trial testing Contact the patient in Hepatitis C Virus Infection in 600 participants. Completed in 31 July 2025.

Timeline
6 July 2023
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorUniversitair Ziekenhuis Brussel
StatusCompleted
Study typeOBSERVATIONAL
Enrollment600
Start date6 July 2023
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universitair Ziekenhuis Brussel — full company profile →

Who can join

18 and older, any sex, with Hepatitis C Virus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reintroduction of patients into a HCV infection care pathway after a positive chronic hepatitis C diagnosis by previous testing in our hospital who were lost in follow-up. Gaining insight in the possible reasons why patients are lost in follow-up after positive hepatitis C serology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hepatitis C Virus Infection

Currently open trials in the same condition.

Other Universitair Ziekenhuis Brussel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05975216.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing